Get a glimpse into our company and investor data—powered by the PitchBook Platform
Portfolio of biogeneric rights. The asset consists of the European manufacturing facility and rights to a biogeneric version of filgrastim located in Zagreb, Croatia.
This information is reserved for PitchBook Platform users. To explore PLIVA Hrvatska (Biogenerics Rights)‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.